Invesco Biotechnology & Genome ETF
PBE
#2066
ETF Rang
€0.24 Mrd.
Marktkapitalisierung
🇺🇸 US
Markt
78,80 €
Aktienkurs
0.24%
Veränderung (1 Tag)
43.98%
Veränderung (1 Jahr)
Kategorien

Invesco Biotechnology & Genome ETF - Bestände

ETF-Bestände zum Stand 16. Juli 2026Anzahl der Bestände: 33

Vollständige Bestandsliste

Gewichtung %NameTickerGehaltene Aktien
4.98%
Vertex Pharmaceuticals IncVRTX29366
4.94%
Amgen IncAMGN38102
4.85%
Royalty Pharma PLCRPRX237665
4.83%
Biogen IncBIIB66296
4.78%
Regeneron Pharmaceuticals IncREGN20169
4.56%
CareDx IncCDNA324147
4.55%
Gilead Sciences IncGILD95721
4.28%
Alnylam Pharmaceuticals IncALNY43319
4.08%
United Therapeutics CorpUTHR22127
3.64%
Bio-Techne CorpTECH145555
3.33%
Vericel CorpVCEL199662
3.26%
Veracyte IncVCYT157932
3.22%
Protagonist Therapeutics IncPTGX69833
3.19%
Illumina IncILMN48078
3.14%
Repligen CorpRGEN60614
2.94%
ACADIA Pharmaceuticals IncACAD328418
2.93%
Incyte CorpINCY71907
2.85%
QIAGEN NVQGEN196461.3786
2.83%
PTC Therapeutics IncPTCT103212
2.76%
BioMarin Pharmaceutical IncBMRN132040
2.75%
Halozyme Therapeutics IncHALO101605
2.71%
Exelixis IncEXEL139699
2.68%
Neurocrine Biosciences IncNBIX44836
2.62%
BioCryst Pharmaceuticals IncBCRX824338
2.62%
Collegium Pharmaceutical IncCOLL206694
2.52%
Sarepta Therapeutics IncSRPT418846
2.28%
AnaptysBio IncANAB120862
2.00%
Ardelyx IncARDX1117146
1.93%
Omeros CorpOMER599328
1.87%
Legend Biotech CorpLEGN236443
0.08%
Invesco Government & Agency PortfolioAGPXX229088.83
0.00%
USD Pending Dividends0
0.00%
CASH & EQUIVALENTSUSD-4541.31